Ryan J. Watts

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

DNLI

Current role

CEO, Board Member

2015-01-01–present

2 calls Latest call 2026-08-06

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$718,000	$676,706	$1,151,867	$2,180,003	—	$24,939	$4,751,515
2024	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$690,100	$627,969	$1,819,942	$3,405,851	—	$13,800	$6,557,662
2023	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$670,000	$462,289	$2,272,291	$4,461,487	—	$13,200	$7,879,267
2022	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$645,000	$387,000	$2,930,740	$5,309,748	—	$12,200	$9,284,688
2021	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$610,104	$503,335	$4,251,600	$7,296,840	—	$11,600	$12,673,479
2020	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$589,472	$648,419	$2,596,305	$5,456,849	—	$11,400	$9,302,445
2019	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$566,800	$311,740	$838,168	$3,252,452	—	$9,447	$4,978,607
2018	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$545,000	$524,563	—	$4,914,360	—	—	$5,983,923
2017	Denali Therapeutics Inc. (DNLI)	President and Chief Executive Officer	$481,056	$374,688	—	$497,350	—	$13,769	$1,366,863

Earnings-call appearances and filed executive appointments or departures, newest first.